NVSEF:OTCMKTS
Novartis AG
137,80 USD
0,00%
(0,00) 1D
13-окт., 15:55:14 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVSEF...
Mkt. cap
300,82 млд
Avg. vol.
30,97 миң
Volume
149,00
52-wk high
171,29 USD
52-wk low
120,00 USD
Beta
0,40
Shares outstanding
2,03 млд
No. of employees
75 миң
Mkt. cap
300,82 млд
Avg. vol.
30,97 миң
Volume
149,00
52-wk high
171,29 USD
52-wk low
120,00 USD
Beta
0,40
Shares outstanding
2,03 млд
No. of employees
75 миң
News stories
From web sources and news partners
GuruFocus
·
4 саат мурун
Novartis AG (NVS) Stock Up 3.1% but GF Value Says Overvalued -- GF Score: 68/100
Global Arbitration Review
·
5 саат мурун
US biotech company enforces eye treatment award against Novartis
Quiver Quantitative
·
7 саат мурун
Why Novartis (NVS) Stock Is Up Today
ad-hoc-news.de
·
10 саат мурун
Bank of America keeps CHF 150.00 target for Novartis stock
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75,3 миң
Founded1996-ж., 7-мар.
HeadquartersБазель, Базель-Штадт, Швейцария
SectorPharmaceutical industry
Websitenovartis.com